Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose AmBisome for visceral leishmaniasis in Bangladesh Upazila Health Complexes
ACTRN12612000367842Phase 4Recruiting
- Sponsor
- World Health Organization
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amphotericin b in visceral leishmaniasis (VL), sponsored by World Health Organization. Primary endpoints: Operational feasibility of treatment delivery and Final cure rate. Started Mar 2012; status: recruiting.
02
Drugs
amphotericin b
03
Conditions
visceral leishmaniasis (VL)
Beyond the preview
Go deeper on ACTRN12612000367842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000367842.